Keros Therapeutics, Inc. (NASDAQ:KROS) Receives $81.33 Consensus Price Target from Analysts
Keros Therapeutics, Inc. (NASDAQ:KROS – Get Free Report) has earned a consensus recommendation of “Moderate...
Your Source for Insightful Trends and Discussions.
Keros Therapeutics, Inc. (NASDAQ:KROS – Get Free Report) has earned a consensus recommendation of “Moderate...
Invesco Ltd. (NYSE:IVZ – Get Free Report) has received an average recommendation of “Hold” from...
Zoetis Inc. (NYSE:ZTS – Get Free Report) has been assigned an average recommendation of “Buy”...
EOG Resources (NYSE: EOG) has recently received a number of price target changes and ratings...
Shares of Semtech Co. (NASDAQ:SMTC – Get Free Report) have been given a consensus rating...
Brookfield Asset Management Ltd. (NYSE:BAM – Get Free Report) (TSE:BAM.A) has earned an average rating...
The Cigna Group (NYSE:CI – Get Free Report) has received an average rating of “Buy”...
Shares of Warner Bros. Discovery, Inc. (NASDAQ:WBD – Get Free Report) have been given a...
Liquidia Co. (NASDAQ:LQDA – Get Free Report) has earned a consensus recommendation of “Buy” from...
Shares of Stanley Black & Decker, Inc. (NYSE:SWK – Get Free Report) have been given...
Several brokerages have updated their recommendations and price targets on shares of Edwards Lifesciences (NYSE:...